Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.85B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$653M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$629M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$591M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.17B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$981M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$416M |
| 4 |
Amazon
AMZN
|
+$402M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.9% |
| 2 | Healthcare | 5.31% |
| 3 | Financials | 5.25% |
| 4 | Communication Services | 4.61% |
| 5 | Consumer Discretionary | 4.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Krystal Biotech
KRYS
$9.72B
| $777K | ﹤0.01% |
+37,389
| New | +$783K |
|
|
HA
3327
CALL
DELISTED
Hawaiian Holdings, Inc.
HA
| $774K | ﹤0.01% |
29,300
+3,700
| +14% | +$125K |
|
|
COHR
3328
DELISTED
Coherent Inc
COHR
| $774K | ﹤0.01% |
7,322
-1,243
| -15% | -$160K |
|
|
GTT
3329
DELISTED
GTT Communications, Inc.
GTT
| $773K | ﹤0.01% |
32,680
+14,763
| +82% | +$497K |
|
3330
Customers Bancorp
CUBI
$2.82B
| $772K | ﹤0.01% |
42,421
-7,183
| -14% | -$144K |
|
|
CUB
3331
DELISTED
Cubic Corporation
CUB
| $772K | ﹤0.01% |
14,372
-33,204
| -70% | -$2.09M |
|
3332
Moelis & Co
MC
$5.21B
| $771K | ﹤0.01% |
22,441
+1,994
| +10% | +$84.7K |
|
|
TEUM
3333
DELISTED
Pareteum Corporation
TEUM
| $771K | ﹤0.01% |
456,500
+286,500
| +169% | +$595K |
|
3334
CBIZ
CBZ
$2.96B
| $770K | ﹤0.01% |
39,054
-22,136
| -36% | -$473K |
|
|
PACD
3335
DELISTED
Pacific Drilling S.A. Common Shares
PACD
| $770K | ﹤0.01% |
+57,663
| New | +$735K |
|
3336
CALL
CBRE Group
CBRE
$44B
| $769K | ﹤0.01% |
19,200
+14,200
| +284% | +$587K |
|
3337
Federal Signal
FSS
$7.51B
| $769K | ﹤0.01% |
38,664
-27,786
| -42% | -$633K |
|
3338
CALL
Healthpeak Properties
DOC
$14.3B
| $768K | ﹤0.01% |
27,500
+5,500
| +25% | +$152K |
|
|
WCC
3339
CALL
WESCO International
WCC
$17.5B
| $768K | ﹤0.01% |
16,000
+9,900
| +162% | +$514K |
|
|
CY
3340
CALL
DELISTED
Cypress Semiconductor
CY
| $768K | ﹤0.01% |
60,400
-8,700
| -13% | -$115K |
|
3341
BrightView Holdings
BV
$1.08B
| $767K | ﹤0.01% |
75,205
+65,946
| +712% | +$848K |
|
3342
PUT
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$168M
| $766K | ﹤0.01% |
12,200
+9,500
| +352% | +$638K |
|
3343
CALL
Baker Hughes
BKR
$63B
| $765K | ﹤0.01% |
35,600
+6,800
| +24% | +$174K |
|
3344
iShares MSCI USA Min Vol Factor ETF
USMV
$24.6B
| $765K | ﹤0.01% |
14,608
+13,899
| +1,960% | +$764K |
|
|
LION
3345
DELISTED
Fidelity Southern Corporation
LION
| $764K | ﹤0.01% |
29,338
+3,707
| +14% | +$87.3K |
|
3346
Eagle Bancorp
EGBN
$877M
| $762K | ﹤0.01% |
15,644
-271
| -2% | -$13.8K |
|
3347
PUT
Toll Brothers
TOL
$14B
| $761K | ﹤0.01% |
23,100
-38,900
| -63% | -$1.25M |
|
|
MIC
3348
PUT
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $760K | ﹤0.01% |
20,800
-24,700
| -54% | -$989K |
|
3349
Editas Medicine
EDIT
$432M
| $759K | ﹤0.01% |
33,364
+15,183
| +84% | +$413K |
|
|
FITB
3350
PUT
Fifth Third Bancorp
FITB
$52.5B
| $758K | ﹤0.01% |
32,200
-57,900
| -64% | -$1.52M |
|
Similar funds
Barclays's Q4 2018 Portfolio in Review
As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.
By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.
- Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
- Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
- Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
- Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
- Barclays opened 489 new positions and closed 777 in Q4 2018.
- Barclays's portfolio value fell 10% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.